Nouveau Logo communiqué de presse.JPG
Theratechnologies fera une présentation à la 25e conférence annuelle mondiale de H.C. Wainwright pour les investisseurs
September 07, 2023 13:57 ET | Theratechnologies
MONTRÉAL , 07 sept. 2023 (GLOBE NEWSWIRE) -- Theratechnologies Inc. (« Theratechnologies » ou la « Société ») (TSX : TH) (NASDAQ : THTX), une société biopharmaceutique axée sur la mise au...
Nouveau Logo communiqué de presse.JPG
Theratechnologies to Present at the H.C. Wainwright 25th Annual Global Investment Conference
September 07, 2023 13:57 ET | Theratechnologies
MONTREAL, Sept. 07, 2023 (GLOBE NEWSWIRE) -- Theratechnologies Inc. (“Theratechnologies” or the “Company”) (TSX: TH) (NASDAQ: THTX), a biopharmaceutical company focused on the development and...
fortressbio1.jpg
Fortress Biotech to Present at H.C. Wainwright 25th Annual Global Investment Conference
September 07, 2023 08:30 ET | Fortress Biotech, Inc.
MIAMI, Sept. 07, 2023 (GLOBE NEWSWIRE) -- Fortress Biotech, Inc. (Nasdaq: FBIO) (“Fortress”), an innovative biopharmaceutical company focused on efficiently acquiring, developing and commercializing...
checkpoint.jpg
Checkpoint Therapeutics to Present at H.C. Wainwright 25th Annual Global Investment Conference
September 06, 2023 08:30 ET | Checkpoint Therapeutics, Inc
WALTHAM, Mass., Sept. 06, 2023 (GLOBE NEWSWIRE) -- Checkpoint Therapeutics, Inc. (“Checkpoint”) (Nasdaq: CKPT), a clinical-stage immunotherapy and targeted oncology company, today announced that...
logo color s and clearside.jpg
Clearside Biomedical to Participate in Three Upcoming Investor Conferences in August 2022
August 03, 2022 07:05 ET | Clearside Biomedical, Inc.
ALPHARETTA, Ga., Aug. 03, 2022 (GLOBE NEWSWIRE) -- Clearside Biomedical, Inc. (NASDAQ:CLSD), a biopharmaceutical company revolutionizing the delivery of therapies to the back of the eye through the...